Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
6.46
-0.27 (-4.01%)
Aug 8, 2025, 11:31 AM - Market open
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $167.13 million as of August 8, 2025. Its market cap has decreased by -69.77% in one year.
Market Cap
167.13M
Enterprise Value
4.38M
1-Year Change
-69.77%
Ranking
Category
Stock Price
6.46
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has decreased from $402.09M to $167.13M, a decrease of -58.43%. That is a compound annual growth rate of -48.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 174.12M | -53.89% |
| Dec 31, 2024 | 377.64M | -6.08% |
| Apr 5, 2024 | 402.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 575.32B |
| Johnson & Johnson | 413.10B |
| AbbVie | 351.30B |
| Abbott Laboratories | 229.85B |
| AstraZeneca | 227.78B |
| Novartis AG | 223.01B |
| UnitedHealth Group | 221.95B |
| Novo Nordisk | 213.92B |